Ad-RTS-hIL-12 and Veledimex
ATI001-201
Phase 2 gene_therapy terminated
Quick answer
Ad-RTS-hIL-12 and Veledimex for Breast Cancer Nos Metastatic Recurrent is a Phase 2 program (gene_therapy) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Breast Cancer Nos Metastatic Recurrent
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- terminated